9056
N. Kaval et al. / Tetrahedron 61 (2005) 9052–9057
4.3. Solvent-free cyclization of 3c on aluminum oxide
(d, 1H, JZ14.6 Hz), 4.85 (d, 1H, JZ14.6 Hz), 4.32 (dd, 1H,
3JZ8, 3.7 Hz), 3.69 (m, 1H), 2.72 (m, 1H), 2.03 (m, 1H),
1.75 (m, 4H), 1.50 (m, 1H). 13C NMR (CDCl3): 146.0,
127.8, 125.0, 124.2, 120.1, 115.7, 86.5, 67.9, 47.3, 31.8,
25.6, 21.8. DEPT (CDCl3): 127.8, 125.0, 120.1, 115.7, 86.5,
K67.9, K47.3, K31.8, K25.6, K21.8. MS (CI): m/z (%)Z
190 (100) [MHC]. HR-MS (EI): C12H15ON calcd
189.11536, found 189.11484.
Neutral alumina (0.8 g) was added to a solution of 3c
(0.17 g, 0.5 mmol) in dichloromethane (1 mL) and the
solvent was evaporated under reduced pressure. The
resulting yellowish powder was transferred to a vial and
heated in an oil bath at 175 8C for 7 min or irradiated at
175 8C for 7 min (hold time) at 300 W maximum power.
The vial was cooled to room temperature, the crude mixture
was transferred to the top of a column filled with silica gel
and purified using dichloromethane–ethylacetate (1:9) as
eluent to give an analytically pure sample of 4c in 55%
yield.
4.4.4. 8-Methoxy-2,3,4,4a-tetrahydro-1H,6H-pyrido-
[1,2-a][3,1]benzoxazine (10d). H NMR (CDCl3): d 6.90
1
3
4
(d, 1H, JZ8.8 Hz), 6.76 (dd, 1H, JZ8.8 Hz, JZ2.9 Hz),
6.50 (d, 1H, JZ2.9 Hz), 4.99 (d, 1H, JZ14.6 Hz), 4.84 (d,
1H, JZ14.6 Hz), 4.31 (q, 1H, JZ2.9 Hz), 3.76 (s, 3H), 3.45
(m, 1H), 2.78 (m, 1H), 1.97 (m, 1H), 1.76 (m, 4H), 1.51 (m,
1H). 13C NMR (CDCl3): 154.4, 140.5, 126.5, 119.4, 113.7,
110.0, 86.3, 67.9, 55.9, 48.9, 31.4, 25.7, 20.9. DEPT
(CDCl3): 119.4, 113.7, 110.0, 86.3, K67.9, 55.9, K48.9,
K31.4, K25.7, K20.9. MS (CI): m/z (%)Z220 (100)
[MHC]. HR-MS (EI): C13H17O2N calcd 219.12593, found
219.12549.
4.4. Typical procedures for MW-assisted cyclizations of
ortho-(10-azacyclo-alkyl)benzaldehydes
(A). In water. A suspension of aldehyde 9a–f (1 mmol) and
K2CO3 (1 mmol) in water (3 mL) was irradiated in closed
vessels with pressure control at 200 8C for 60 min (hold
time) at 90 W maximum power. The reaction mixture was
extracted with dichloromethane (10 mL!3). The combined
organic layers were dried over Mg2SO4, filtered and
evaporated. The residue was subjected to column chroma-
tography on silica gel (eluent: dichloromethane–hexanes
1:1) for compounds 10a–c or dichloromethane for
compounds 10d–f, 11e,f to afford benzoxazines 10a–f and
alcohols 11e,f as oils.
4.4.5. 1,2,4,4a-Tetrahydro-6H-[1,4]oxazino[4,3-a][3,1]-
1
benzoxazine (10e). H NMR (CDCl3): d 7.20 (t, 1H, JZ
7.3 Hz), 6.89 (m, 3H), 5.05 (d, 1H, JZ14.6 Hz), 4.90 (d,
3
1H, JZ14.6 Hz), 4.37 (dd, 1H, JZ7, 3.6 Hz), 3.99 (m,
2H), 3.66 (m, 2H), 3.18 (t, 1H, JZ5.1 Hz), 2.96 (m, 1H).
MS (CI): m/z (%)Z192 (100) [MHC]. HR-MS (EI):
C11H13O2 calcd 191.09463, found 191.09509.
(B). On alumina. A solution of aldehyde 9a–f (1 mmol) in
dichloromethane (0.5 mL) was added to a mixture of
Al2O3–KF (0.4 g, 3:1 w/w) and the solvent was evaporated
under reduced pressure. The resulting yellowish powder
was irradiated at 200 8C for 60 min at 100 W power, cooled
to room temperature, applied on the top of a column with
silica gel and purified as indicated under (A).
4.4.6. 8-Methoxy-1,2,4,4a-tetrahydro-6H-[1,4]oxazino-
[4,3-a][3,1]benzoxazine (10f). H NMR (CDCl3): d 6.87
1
3
4
(d, 1H, JZ8.8 Hz), 6.76 (dd, 1H, JZ8.8 Hz, JZ2.9 Hz),
6.53 (d, 1H, JZ2.9 Hz), 5.02 (d, 1H, JZ14.6 Hz), 4.90 (d,
1H, JZ14.6 Hz), 4.29 (q, 1H, JZ2.9 Hz), 3.91 (m, 4H),
3.77 (s, 3H), 3.42 (m, 1H), 2.93 (m, 1H). 13C NMR (CDCl3):
155.0, 139.6, 126.5, 119.6, 113.9, 110.1, 82.9, 69.4, 67.7,
67.3, 55.9, 48.1. DEPT (CDCl3): 119.6, 113.9, 110.1, 82.9,
K69.4, K67.7, K67.3, 55.9, K48.1. MS (CI): m/z (%)Z
222 (100) [MHC].
4.4.1. 1,2,3,3a-Tetrahydro-5H-pyrrolo[1,2-a][3,1]benz-
oxazine (10a). 1H NMR (CDCl3): d 7.16 (t, 1H, JZ
7.3 Hz), 6.93 (d, 1H, JZ7.3 Hz), 6.75 (t, 1H, JZ7.3 Hz),
6.71 (d, 1H, JZ8 Hz), 4.96 (d, 1H, JZ14.6 Hz), 4.95 (m,
1H), 4.77 (d, 1H, JZ14.6 Hz), 3.62 (m, 1H), 3.27 (m, 1H),
2.35 (m, 1H), 2.01 (m, 3H). 13C NMR (CDCl3): 143.6,
128.1, 125.1, 122.0, 118.3, 115.6, 89.9, 68.6, 50.1, 32.8,
23.0. DEPT (CDCl3): 128.1, 125.1, 118.3, 115.6, 89.9,
K68.6, K50.1, K32.8, K23.0. MS (CI): m/z (%)Z176
(100) [MHC]. HR-MS (EI): C11H13ON calcd 175.09971,
found 175.09869.
4.4.7. (2-Morpholinophenyl)methanol (11e). 1H NMR
(CDCl3): d 7.23 (m, 4H), 4.98 (br s, 1H), 4.83 (s, 2H), 3.89
(t, 4H, JZ4.4 Hz), 3.01 (t, 4H, JZ4.4 Hz). 13C NMR
(CDCl3): 150.9, 136.0, 129.2, 128.9, 125.5, 121.1, 67.9,
64.8, 53.2. DEPT (CDCl3): 129.2, 128.9, 125.5, 121.1,
K67.9, K64.8, K53.2. MS (CI): m/z (%)Z194 (26)
[MHC], 176 (31) [MHCKH2O].
4.4.2. 7-Methoxy-1,2,3,3a-tetrahydro-5H-pyrrolo[1,2-a]
[3,1]benzoxazine (10b). H NMR (CDCl3): d 6.76 (d, 2H,
1
JZ1.5 Hz), 6.52 (s, 1H), 4.90 (d, 1H, JZ14.6 Hz), 4.87 (m,
1H), 4.73 (d, 1H, JZ14.6 Hz), 3.76 (s, 3H), 3.59 (m, 1H),
3.17 (m, 1H), 2.33 (m, 1H), 1.99 (m, 3H). 13C NMR
(CDCl3): 153.4, 133.7, 124.3, 119.1, 114.1, 110.4, 90.1,
68.2, 56.1, 51.9, 32.9, 23.2. DEPT (CDCl3): 119.1, 114.1,
110.4, 90.1, K68.2, 56.1, K51.9, K32.9, K23.2. MS (CI):
m/z (%)Z206 (100) [MHC]. HR-MS (EI): C12H15O2N
calcd 205.11028, found 205.10572.
4.4.8. (5-Methoxy-2-morpholinophenyl)methanol (11f).
1H NMR (CDCl3): d 7.17 (d, 1H, JZ8.1 Hz), 6.82 (dd, 1H,
4
3JZ8.1 Hz, JZ2.9 Hz), 6.75 (d, 1H, JZ2.9 Hz), 4.78 (s,
2H), 3.86 (t, 4H, JZ4.4 Hz), 3.80 (s, 3H), 2.94 (t, 4H, JZ
4.4 Hz). 13C NMR (CDCl3): 157.4, 143.9, 137.6, 122.6,
114.3, 113.6, 67.9, 65.1, 55.8, 53.6. DEPT (CDCl3): 122.6,
114.3, 113.6, K67.9, K65.1, 55.8, K53.6. MS (CI): m/z
(%)Z224 (62) [MHC], 206 (31) [MHCKH2O], 194 (6)
[MHCKMe2O]. HR-MS (EI): C12H17O3N calcd
223.12084, found 223.12110.
4.4.3. 2,3,4,4a-Tetrahydro-1H,6H-pyrido[1,2-a][3,1]-
1
benzoxazine (10c). H NMR (CDCl3): d 7.17 (t, 1H, JZ
7.3 Hz), 6.93 (d, 2H, JZ8 Hz), 6.85 (t, 1H, JZ7.3 Hz), 5.02